A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/365 (2006.01)
Patent
CA 2254121
This invention is directed to a pharmaceutical composition for the treatment of cyclooxygenase-2 mediated diseases, said composition being suitable for once a day oral administration, said composition comprising 2.5 to 250 mgs of 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone. The invention is also directed to a method of treating cyclooxygenase-2 mediated diseases comprising the once a day oral administration of 2.5 to 250 mgs of 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl)-2-(5H)- furanone. The invention is also directed to the use of 5,5-dimethyl-3-(3- fluorophenyl)-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone in the manufacture of a medicament containing 2.5 to 250 mgs of said compound for once a day administration for the treatment of cyclooxygenase-2 mediated diseases.
L'invention concerne une composition pharmaceutique de traitement de maladies à médiation cyclooxygénase-2, cette composition pouvant être administrée une fois par jour par voie orale et contenant de 2,5 à 250 mg de 5,5 -diméthyl-3-(3 fluorophényl)-4-(4-méthylsulfonyl)phényl)-2-(5H)-furanone. L'invention concerne également une méthode pour traiter les maladies à médiation cyclooxygénase-2 comprenant l'administration d'une dose quotidienne de 2,5 à 250 mg de 5,5 -diméthyl-3-(3 fluorophényl)-4-(4-méthylsulfonyl)phényl)-2-(5H)-furanone. L'invention concerne également une utilisation de 5,5 -diméthyl-3-(3 fluorophényl)-4-(4-méthylsulfonyl)phényl)-2-(5H)-furanone dans la production d'un médicament contenant entre 2,5 et 250 mg dudit composé à administrer à raison d'une dose quotidienne pour le traitement de maladies à médiation cyclooxygénase-2.
Gertz Barry
Gottesdiener Keith
Hancock Bruno
Winters Conrad
Merck & Co. Inc.
Merck Frosst Canada Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Compositions for a once a day treatment of cyclooxygenase-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for a once a day treatment of cyclooxygenase-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for a once a day treatment of cyclooxygenase-2... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1850918